These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 1252046

  • 1. Letter: Disseminated intravascular coagulation syndrome with metastatic melanoma: Remission after treatment with 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC).
    Susens GP, Hendrickson C, Barto DA, Sams BJ.
    Ann Intern Med; 1976 Feb; 84(2):175-6. PubMed ID: 1252046
    [No Abstract] [Full Text] [Related]

  • 2. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ, Falkson G.
    Med Pediatr Oncol; 1975 Feb; 1(2):107-11. PubMed ID: 1228411
    [Abstract] [Full Text] [Related]

  • 3. Combination chemotherapy with bis chloroethyl nitrosourea (BCNU), vincristine and dimethyl triazeno imidazole carboxamide (DTIC) in disseminated malignant melanoma.
    McKelvey EM, Luce JK, Talley RW, Hersh EM, Hewlett JS, Moon TE.
    Cancer; 1977 Jan; 39(1):1-4. PubMed ID: 832224
    [Abstract] [Full Text] [Related]

  • 4. [Dimethyl-triazeno-imidazol-carboxamide (DTIC)--a new cytostatic agent].
    Klepp O.
    Tidsskr Nor Laegeforen; 1975 Sep 30; 95(27):1550-1. PubMed ID: 1179374
    [No Abstract] [Full Text] [Related]

  • 5. Value of adjuvant therapy with bacille Calmette Guerin (BCG) or dimethl triazeno imidazole carboximide (DTIC) in the control of minimal residual disease in stage II melanoma.
    Peter HH, Deutschmann KE, Deinhardt J, Deicher H.
    Recent Results Cancer Res; 1978 Sep 30; 68():367-74. PubMed ID: 752872
    [No Abstract] [Full Text] [Related]

  • 6. Comparative study of methyl-CCNU (NSC-95441) with cyclophosphamide (NSC-26271) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) with vincristine (NSC-67574) in patients with disseminated malignant melanoma.
    Ahmann DL, Hahn RG, Bisel HF, Eagan RT, Edmonson JH.
    Cancer Chemother Rep; 1975 Sep 30; 59(2 Pt 1):451-3. PubMed ID: 1097102
    [No Abstract] [Full Text] [Related]

  • 7. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G, Giraldi T, Lassiani L, Nisi C.
    Cancer Res; 1984 Jan 30; 44(1):64-8. PubMed ID: 6690062
    [Abstract] [Full Text] [Related]

  • 8. Bis chloroethyl nitrosourea, vincristine, dimethyl triazeno imidazole carboxamide and chlorpromazine combination chemotherapy in disseminated malignant melanoma.
    McKelvey EM, Luce JK, Vaitkevicius VK, Talley RW, Bodey GP, Lane M, Moon TE.
    Cancer; 1977 Jan 30; 39(1):5-10. PubMed ID: 832251
    [Abstract] [Full Text] [Related]

  • 9. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma.
    Costanza ME, Nathanson L, Costello WG, Wolter J, Brunk SF, Colsky J, Hall T, Oberfield RA, Regelson W.
    Cancer; 1976 Apr 30; 37(4):1654-9. PubMed ID: 769936
    [Abstract] [Full Text] [Related]

  • 10. Study of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) in patients with disseminated melanoma.
    Gerner RE, Moore GE.
    Cancer Chemother Rep; 1973 Feb 30; 57(1):83-4. PubMed ID: 4704107
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Chemotherapy of disseminated malignant melanoma with dimethyl triazeno imidazole carboxamide and dactinomycin.
    Gerner RE, Moore GE, Didolkar MS.
    Cancer; 1973 Oct 30; 32(4):756-60. PubMed ID: 4751912
    [No Abstract] [Full Text] [Related]

  • 13. Combined DTIC and cis-dichlorodiammineplatinum(II) therapy for patients with disseminated melanoma: a Northern California Oncology Group study.
    Friedman MA, Kaufman DA, Williams JE, Resser KJ, Rosenbaum EH, Cohen RJ, Glassberg AB, Blume MR, Gershow J, Chan EY.
    Cancer Treat Rep; 1979 Mar 30; 63(3):493-5. PubMed ID: 371802
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Combination cytotoxic chemotherapy for metastatic cutaneous malignant melanoma with DTIC, BCNU, and vincristine.
    Carmo-Pereira J, Oliveira Costa F, Pimentel P.
    Cancer Treat Rep; 1976 Sep 30; 60(9):1381-3. PubMed ID: 1016972
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [DTIC in the therapy of solid tumours (author's transl)].
    Kokron O, Pridun N, Zischinsky W.
    Wien Klin Wochenschr; 1978 Dec 22; 90(24):864-7. PubMed ID: 741753
    [Abstract] [Full Text] [Related]

  • 20. Effect of cobalt-60 gamma rays and DTIC (5-(3,3 dimethyl-1-triazeno)-imidazole-r-carboxamide) on human malignant melanomas grown in athymic nude mice.
    Rofstad EK, Brustad T, Johannessen JV, Mossige J.
    Br J Radiol; 1977 May 22; 50(593):314-20. PubMed ID: 861450
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.